RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Genetics and Genomics

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death, with rising incidence despite current treatments.
• Novel therapeutic strategies are crucial to combat the increasing burden of cardiovascular diseases.
• RNA editing, particularly adenosine-to-inosine (A-to-I) conversion by ADARs, influences RNA function and gene expression.

Approach:

• This review introduces fundamental concepts of RNA editing.
• It highlights the link between RNA editing and cardiovascular disease pathophysiology.
• The focus is on the therapeutic applications of RNA editing in cardiovascular medicine.

Key Points:

• Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by ADAR enzymes, is a key post-transcriptional modification.
• Dysregulation of RNA editing has been implicated in the development of cardiovascular diseases.
• Targeting RNA editing pathways offers a novel therapeutic avenue for cardiovascular conditions.

Conclusions:

• RNA editing represents a promising frontier for developing innovative treatments for cardiovascular diseases.
• Further research into RNA editing mechanisms and therapeutic exploitation is warranted.
• Harnessing RNA editing could lead to precise and efficient interventions for cardiovascular conditions.